Nebivolol in complex treatment of patients with coronary heart disease and chronic obstructive pulmonary disease

Nebivolol in complex treatment of patients with coronary heart disease and chronic obstructive pulmonary disease

.

Saved in:

Bibliographic Details
Main Authors:	A. G. Evdokimova, A. E. Radzevich, O. I. Tereshchenko, E. V. Kovalenko, M. B. Lozhkina, T. A. Komissarova, V. V. Evdokimov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2007-02-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2030
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nebivolol in complex therapy of patients with coronary heart disease and chronic heart failure
by: A. G. Yevdokimova, et al.
Published: (2004-08-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Monocinque clinical effectiveness in complex treatment of patients with chronic heart failure, functional class II-III angina, and chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2007-04-01)

ACE inhibitor in complex therapy of functional class II-III chronic heart failure in patients with chronic obstructive pulmonary disease
by: A. G. Evdokimova, et al.
Published: (2005-12-01)

EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
by: N. A. Koryagina, et al.
Published: (2014-12-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

INFLUENCE OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON POST-OPERATION COURSE IN CORONARY HEART DISEASE
by: A. S. Klinkova, et al.
Published: (2016-04-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

Superselective beta-adrenoblocker Nebivolol in patients with cardiovascular pathology and obstructive pulmonary syndrome
by: S. I. Ovcharenko, et al.
Published: (2006-04-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

IVABRADINE EFFECTIVENESS IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
by: I. V. Kochetkova, et al.
Published: (2014-04-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)

Modern opportunities for optimising the treatment of patients with coronary heart disease and arterial hypertension: role of zofenopril
by: A. G. Evdokimova, et al.
Published: (2012-08-01)

The relationship of chronic obstructive pulmonary disease and coronary heart disease: problems of pathogenesis and treatment strategy
by: O. V. Yatsenko
Published: (2014-06-01)

The phenotypes of chronic heart failure in patients with ischemic heart disease combined with chronic obstructive pulmonary disease.
by: V. A. Potabashniy
Published: (2018-10-01)

High-definition electrocardiography, heart rate variability and QT interval assessment in coronary heart disease diagnostics during professional medical examination of railroad workers
by: A. E. Radzevich, et al.
Published: (2006-02-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

FEATURES OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH COMBINATION STABLE ANGINA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. K. Zafiraki, et al.
Published: (2014-06-01)

ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)

The dynamics of 24-hour ambulatory blood pressure monitoring parameters, subclinical damage and endothelial function of vessels in patients with arterial hypertension and chronic obstructive pulmonary disease treated with S-amlodipine, Nebivolol and Enala
by: O. G. Ivanko, et al.
Published: (2017-02-01)

Systemic enzyme therapy and clinical and hemorheological parameters in coronary heart disease patients with effort angina
by: A. Yu. Konyakhin, et al.
Published: (2005-06-01)

EVALUATING THE CLINICAL AND HEMODYNAMICAL ACTION OF NEBIVOLOL IN CHRONIC HEART FAILURE
by: M. A. Gurevich, et al.
Published: (2001-04-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics
by: R. E. Tokmachev, et al.
Published: (2018-12-01)

Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
by: V. A. Gubkina, et al.
Published: (2016-06-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Predictive value of neutrophil to lymphocyte ratio for the complication of coronary heart disease in patients with chronic obstructive pulmonary disease
by: HUANG Minjie*，TAO Jun，LI Jie，WANG Zhi，LU Zhiping，XU Junwei
Published: (2025-06-01)

COMPARE THE EFFECTIVENESS OF NEBIVOLOL AND SOTALOL IN PATIENTS WITH HYPERTENSIVE DISEASE AND VENTRICULAR ARRHYTHMIAS
by: I. Z. Shubitidze, et al.
Published: (2016-09-01)

Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease
by: M. E. Statsenko, et al.
Published: (2008-12-01)

ENDOVASCULAR TREATMENT FOR CHRONIC CORONARY OCCLUSIONS IN PATIENTS WITH CORONARY HEART DISEASE
by: R. O. Shirokov, et al.
Published: (2016-02-01)

Optimization of Treatment of Patients with Chronic Cardiac Insufficiency of the Ischemic Genesis and Hobnail Liver
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

The effect of chronic obstructive pulmonary disease on the level of homocysteinemia and the condition of coronary vessels in patients with myocardial infarction
by: T. V. Prokofieva, et al.
Published: (2019-11-01)

Optimization of the Treatment of Patients with Chronic Cardiac Insufficiency and Cardiopulmonary Pathology
by: A. G. Evdokimova, et al.
Published: (2020-05-01)

CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN: ROLE OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE
by: N. T. Vatutin, et al.
Published: (2016-08-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)